Home › Merck melanoma drug shrinks tumors in 38 percent of patients
 

Keywords :   


Merck melanoma drug shrinks tumors in 38 percent of patients

2013-06-02 18:54:47| Biotech - Topix.net

A Merck & Co drug designed to unmask tumor cells and mobilize the immune system into fighting cancer helped shrink tumors in 38 percent of patients with advanced melanoma in an early-stage study, U.S. researchers said on Sunday.

Tags: of drug percent patients

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
07.10Mark Andy appoints Antony Cotton European sales manager
07.10Hurricane Milton Potential Storm Surge Flooding Map
07.10Evonik, BASF Agree on First Delivery of Biomass-Balanced Ammonia
07.10Hurricane Milton Update Statement
07.10Summary for Hurricane Milton (AT4/AL142024)
07.10Hurricane Milton Probabilistic Storm Surge Graphics
07.10MCC acquires smart label solutions provider Starport Technologies
07.10UPM Raflatac announces Packaging Recyclability Guide
More »